Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10 Breast 8 Thoracic 4 Other solid neoplasm 2 Gynecologic 2 Tumor-Agnostic 1 NET 1 Head & Neck 1 Genitourinary 1 Endocrine 1 Dermatologic 1 CNS 1

Conditions

Interventions

pembrolizumab 161 Nivolumab 133 Ipilimumab 78 Cyclophosphamide 46 Specimen Handling 43 Magnetic Resonance Spectroscopy 39 cemiplimab 35 Biopsy 31 fludarabine 28 trametinib 24 relatlimab 24 binimetinib 23 Interleukin-2 22 fludarabine phosphate 20 dabrafenib 20 atezolizumab 19 Radiotherapy 19 Opdualag 19 aldesleukin 18 Radiosurgery 18 CTLA-4 Antigen 18 encorafenib 17 Blood Specimen Collection 17 avelumab 14 Immunoglobulin G 14 Disulfides 13 lifileucel 11 lenvatinib 11 Bevacizumab 11 Paclitaxel 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chemotherapy, Adjuvant × Dermatologic × 1 year × Clear all

NCT03567889 2025-12-17

NeoDREAM

Philogen S.p.A.

Phase 3 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡